Excellent Clinical Outcomes and High Retention in Care Among Adults in a Community-Based HIV Treatment Program in Rural Rwanda

Michael Rich(Partners In Health), Ann C. Miller(Harvard Global Health Institute), Peter Niyigena(Partners In Health), Molly F. Franke(Harvard Global Health Institute), Jean Bosco Niyonzima(Partners In Health), Adrienne Socci(Partners In Health), Peter Drobac(Brigham and Women's Hospital), Massudi Hakizamungu(Partners In Health), Alishya Mayfield(Partners In Health), Robert Ruhayisha(Ministry of Health), Henry Epino(Massachusetts General Hospital), Sara Stulac(Partners In Health), Corrado Cancedda(Brigham and Women's Hospital), Adolph Karamaga(Ministry of Health), Saleh Niyonzima(Ministry of Health), Chase Yarbrough(Partners In Health), Julia Fleming(Partners In Health), Cheryl Amoroso(Partners In Health), Joia S. Mukherjee(Partners In Health), Megan Murray(Harvard University), Paul Farmer(Partners In Health), Agnès Binagwaho(Harvard Global Health Institute)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 10, 2011
Cited by 176

Abstract

BACKGROUND: Access to antiretroviral therapy (ART) has rapidly expanded; as of the end of 2010, an estimated 6.6 million people are receiving ART in low-income and middle-income countries. Few reports have focused on the experiences of rural health centers or the use of community health workers. We report clinical and programatic outcomes at 24 months for a cohort of patients enrolled in a community-based ART program in southeastern Rwanda under collaboration between Partners In Health and the Rwandan Ministry of Health. METHODS AND FINDINGS: A retrospective medical record review was performed for a cohort of 1041 HIV+ adult patients initiating community-based ART between June 1, 2005, and April 30, 2006. Key programatic elements included free ART with direct observation by community health worker, tuberculosis screening and treatment, nutritional support, a transportation allowance, and social support. Among 1041 patients who initiated community-based ART, 961 (92.3%) were retained in care, 52 (5%) died and 28 (2.7%) were lost to follow-up. Median CD4 T-cell count increase was 336 cells per microliter [interquartile range: (IQR): 212-493] from median 190 cells per microliter (IQR: 116-270) at initiation. CONCLUSIONS: A program of intensive community-based treatment support for ART in rural Rwanda had excellent outcomes in 24-month retention in care. Having committed to improving access to HIV treatment in sub-Saharan Africa, the international community, including country HIV programs, should set high programmatic outcome benchmarks.


Related Papers

No related papers found

Powered by citation graph analysis